Artemis Distribution

What Artemis Distribution does

Artemis Distribution is a US-headquartered (Rye Brook, NY) exclusive distributor of non-invasive aesthetic devices and operator of a performance-based patient acquisition program, founded in 2018 by Simon Mansell. The company serves medical spas, plastic surgery and dermatology clinics, wellness and cryotherapy centers, and chiropractic and integrative health practices across the USA and UK through a network of 2,700+ partner practices and 505+ certified service providers. Its core products are the FDA-cleared Neogen nitrogen plasma skin regeneration system and the T-Shape 2 multi-technology body contouring device, supplemented by a broader portfolio including Endospheres, InfraBaldan, Plason, Soft FX, and a Neveskin family of devices, with proprietary consumables (T-Shape 2 solution, filters, cleansers) required under warranty.

The business operates a hybrid distribution-plus-services model. Device sales are driven by an enterprise field sales motion and distributed via the partner network and an e-commerce storefront (store.artemis.co) for consumables and accessories. The differentiated layer is a fully managed advertising engine that produces creative, buys media on Meta and Google, runs a call center that qualifies leads, collects deposits, and books confirmed appointments directly into partner schedules. Practices pay $300 per patient who actually shows up, with pilot data across 30+ locations indicating 5-7 new patients per week per clinic and a 5x return on marketing spend. The company holds an exclusive US distribution partnership with Baldan Group, and is led by CEO/Founder Simon Mansell alongside COO & President Kate Lavender, CCO Andrea Trofimuk, and CMO Simon Wardropper.

Name

Artemis Distribution

Legal name

Artemis Distribution LLC

Website

https://artemis.co

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Artemis Distribution is the exclusive US distributor of non-invasive aesthetic devices (Neogen, T-Shape 2, and a broader device portfolio) that combines hardware sales with a pay-per-arrived-patient managed advertising engine serving 2,700+ med spas, plastic surgery clinics, and wellness practices.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Fragrance & Deodorant Distribution (CRAOAEAF)

akta.pro secondary industries

Spa Body Treatments & Massage (Oils, Scrubs, Wraps) (CRABALAG), Professional Skincare & Facial Treatments (CRABALAF)

Keywords

• Aesthetic medical devices
• Medical device distribution
• Body contouring equipment
• Skin regeneration technology
• Performance marketing services

Headquarters

HQ city

Rye

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Aesthetic Device Sales: Sale of Neogen plasma skin regeneration devices and T-Shape 2 body contouring systems to aesthetic practices, med spas, and clinics. Devices are sold with flexible financing options. Delivery typically takes 1-3 months after purchase following mandatory onboarding process.
2. Pay-Per-Arrived-Patient Marketing: Performance-based marketing service where Artemis charges practices only when a patient actually shows up for their appointment. Based on pilot data, average booking generates $1,500 in profit for practices at $300 per arrived patient, representing 5x return on investment.
3. Consumables and Accessories: Ongoing sales of consumables including T-Shape 2 solution, filters, cleansers, and other accessories required for device operation. Partners must use specified consumables to maintain warranty.
4. Training and Support Services: Clinical training for staff on device operation, treatment protocols, and practice growth strategies. Includes both online and offline training modules required for certification.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Artemis Distribution is the exclusive US distributor of clinical aesthetic devices — primarily the Neogen nitrogen plasma skin regeneration system and the T-Shape 2 multi-technology body contouring platform — sold to med spas, plastic surgery and dermatology clinics, and wellness centers. The company complements device sales with a fully managed, performance-based patient acquisition program (Meta/Google advertising, call center lead qualification, deposit collection, and appointment booking) billed at $300 per attended appointment. It also sells branded consumables, accessories, clinical training, and support services, and distributes additional brands including Neveskin, Plason, Endospheres, InfraBaldan, and Soft FX.

Product overview

Artemis Distribution is an aesthetic device company that serves as the exclusive distributor of T-Shape 2 and Neogen devices in the USA, along with additional brands including Endospheres, InfraBaldan, Neveskin (Classic, Duo, Face, Ultra), Plason, and Soft-FX. The company combines clinically proven non-invasive aesthetic technologies with a fully managed patient acquisition marketing program. Neogen provides facial skin regeneration using nitrogen plasma technology, while T-Shape 2 delivers body contouring through combined radio frequency, laser therapy, endodermic massage, and muscle activation. Consumables (solutions, filters, cleansers) support device maintenance. The marketing services arm handles advertising, lead management, and appointment booking for partner practices.

Differentiator

Problem solved

Functional benefit

Products and services

• Neogen
• T-Shape 2 Multi-technology face and body treatment system combining bipolar radio frequency, low-level laser therapy (LLLT), endodermic massage with suction, and mesospheric activation. Designed for skin tightening, body contouring, and reduction of visible cellulite; 23% increase in muscle-to-fat ratio after 10 treatments.
• Soft FX
• Endospheres
• InfraBaldan
• Neveskin Classic
• Neveskin Duo
• Neveskin Face
• Neveskin Ultra
• Plason
• T-Shape 2 Solution
• T-Shape 2 Filters
• T-Shape 2 Deep Clean
• Pay-Per-Attended-Patient Marketing Service Fully managed advertising engine providing social media advertising on Meta and Google, call center lead follow-up, deposit collection, and appointment booking services for practice partners. Practices are billed $300 per attended patient with a payback guarantee to reach profitability by month 13.
• Clinical Training and Support Services

Quantifiable outcome

• Up to 80% increase in dermal density with Neogen
• +5 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Baldan GroupcoreChannel Partner/ Reseller/ DistributorArtemis and Baldan Group partnership for T-Shape 2 distribution in the US market. While Artemis is the primary distributor with local US support and consumer marketing, Baldan continues to support its existing US sales representatives. Both sales teams report to Simon Mansell, CEO of Artemis, for unified strategy. Pricing is identical regardless of purchase source.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Galderma: Global dermatology and aesthetics company with a portfolio spanning injectables, skin care, and therapeutic aesthetics. Competes for the same med-spa wallet share and could extend into energy-based devices, threatening Artemis's positioning.
• Merz Aesthetics: Global aesthetics player offering Ultherapy (skin lifting), Radiesse, and Belotero. Operates in the same med-spa and dermatology channel as Artemis with owned devices and a direct US sales force.
• Cynosure (Hologic): Established US aesthetic device manufacturer (lasers, body contouring, skin resurfacing) under Hologic. Directly comparable to Artemis's device distribution and med-spa channel strategy, but at vastly larger scale and with owned IP rather than distribution rights.
• Lumenis (Boston Scientific): Energy-based medical and aesthetic device company (now part of Boston Scientific) offering laser and IPL platforms. Overlaps with Artemis's energy-based device categories and serves a similar physician/med-spa customer base globally.
• Allergan Aesthetics (AbbVie): Owns CoolSculpting (body contouring), Botox, and a broad aesthetics portfolio. Competes with Artemis in non-invasive body sculpting and has the scale and balance sheet to bundle devices with patient acquisition programs — a key competitive threat to Artemis's model.
• Solta Medical (Bausch Health): Established aesthetic device brand under Bausch Health offering Thermage, Fraxel, and Clear+Brilliant. Competes in skin rejuvenation and tightening with owned IP and global distribution — overlapping end customers with Artemis's Neogen positioning.

Direct peers

• Sciton: US-based manufacturer of laser and light-based aesthetic platforms (BBL, Halo, Joule) sold to plastic surgeons and med spas. Closely comparable technology category (energy-based skin rejuvenation) and customer base to Artemis's Neogen plasma platform.
• InMode: Public aesthetic medical device company with proprietary platforms for body contouring, skin tightening, and facial rejuvenation. Competes with Artemis's portfolio in the same med-spa and plastic surgery channel with owned IP and direct sales force.
• Cutera: Public aesthetic device company offering laser, RF, and body contouring systems (truSculpt, AviClear, Secret RF) sold through a similar med-spa and physician channel. Directly comparable product portfolio and customer base to Artemis's Neogen and T-Shape 2 offerings.
• BTL Aesthetics: Manufactures non-invasive body contouring and skin tightening devices (Emsculpt, Emface, Exilis) sold to med spas and aesthetic practices. Closest direct peer to T-Shape 2 — competing technology categories, same end customers, similar capital-equipment sales motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/artemisdistribution
• Facebookfacebook.com/artemisdistribution
• LinkedInlinkedin.com/company/artemis-distribution

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artemis Distribution